9354 Federal Register / Vol. 86, No. 28 / Friday, February 12, 2021 / Notices 

1Centers for Disease Control and Prevention. CDC 

Health Disparities and Inequalities Report—United 

States, 2013. MMWR 2013;62 (Suppl 3). Retrieved 

December 7, 2020 from https://www.cdc.gov/mmwr/ 

pdf/other/su6203.pdf. 

2O’Mara-Eves A., Brunton G., Oliver S., 

Kavanagh J., Jamal F., Thomas J. The effectiveness 

of community engagement in public health 

interventions for disadvantaged groups: A metaanalysis. BMC Public Health. 2015;15:129. 

Published 2015 Feb 12. doi:10.1186/s12889–015– 

1352–y. 

• Preferred method: Submit 

information through the Federal 

eRulemaking Portal at http://

www.regulations.gov. Follow the online 

instructions for submissions. 

• Email: Send comments to 

Paul.Rodriguez@hhs.gov with the 

subject line ‘‘OMH AI/AN RFI: Center 

for Indigenous Innovation and Health 

Equity.’’ 

Submissions received after the deadline 

will not be reviewed. Respond concisely 

and in plain language. You may use any 

structure or layout that presents your 

information well. You may respond to 

some or all of our questions, and you 

can suggest other factors or relevant 

questions. You may also include links to 

online material or interactive 

presentations. Clearly mark any 

proprietary information and place it in 

its own section or file. Your response 

will become government property, and 

we may publish some of its nonproprietary content. 

FOR FURTHER INFORMATION CONTACT: Paul 

Rodriguez, 1101 Wootton Parkway, 

Suite 100, Rockville, MD 20852, (240) 

453–8208, Paul.Rodriguez@hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background Information 

The Office of Minority Health 

Authorized under Section 1707 of the 

Public Health Service Act, 42 U.S.C. 

300u–6, as amended, the mission of 

OMH is to improve the health of racial 

and ethnic minority populations 

through the development of health 

policies and programs that help 

eliminate health disparities. OMH 

awards and other activities are intended 

to support the identification of effective 

policies, programs and practices for 

improving health outcomes and to 

promote sustainability and 

dissemination of these approaches. 

Under the authority of Public Law 

116–260 (2021 Consolidated 

Appropriations Act), Congress called for 

the creation of a Center for Indigenous 

Innovation and Health Equity to support 

efforts including research, education, 

service, and policy development related 

to advancing Indigenous solutions to 

decrease health disparities in the AI/AN 

and NHPI populations. 

Background 

Heath disparities in the AI/AN 

population in the United States include 

higher rates of chronic diseases, 

unintentional injuries and premature 

deaths. The average life expectancy for 

an AI/AN born today would be 4.4 

fewer years than for an individual of 

any other race. Empirical evidence 

indicates that many factors influence 

health, and the strongest predictors of 

chronic disease, unintentional injury, 

and premature death are linked to the 

social determinants of health in AI/AN 

communities. 

Identification and awareness of health 

outcomes and health determinants in 

AI/AN populations are essential steps 

towards reducing health disparities.1

Research has shown that communitydriven interventions have a positive 

impact on health outcomes.2

Program Information 

The purpose of this initiative is to 

create a Center for Indigenous 

Innovation and Health Equity (Center) 

to provide services for American Indian 

and Alaska Native and Native Hawaiian 

and Pacific Islander populations that 

draws on deeply-rooted indigenous 

values and practices. 

The Center should serve as a 

coordinating entity that will partner 

with accredited academic institutions 

with a focus on Indigenous health 

research, policy and innovation among 

AI/AN and NHPI populations. The 

Center will serve to build capacity and 

to support efforts including research, 

education, service, and policy 

development related to advancing 

Indigenous solutions. Work in these 

areas will increase the capacity to 

identify and address health disparities 

in AI/AN and NHPI communities. The 

Center is highly encouraged to engage 

Indigenous leaders and community 

partners to address AI/AN and NHPI 

health disparities focus areas that align 

with their goals and priorities. The 

Center is expected to use a dual track 

approach to address each populations’ 

needs and tailor indigenous knowledge 

and practice specific to the AI/AN and 

NPHI populations. Each track will be 

parallel and complementary, both 

rooted in indigenous values and 

practices appropriate to each 

population. 

The Center’s objectives may include: 

• Create an indigenous public health 

agenda focused on research needs, 

education, services, and health policies 

to address AI/AN and NHPI health 

disparities. 

• Serve as a resource to support the 

development, implementation, 

evaluation, dissemination, and 

translation of evidence-based public 

health interventions in AI/AN and NHPI 

communities. 

• Partner with academic institutions 

and Indigenous leaders and community 

partners in health disparities focus 

areas. 

• Train AI/AN and NHPI public 

health, medical practitioners, students 

and multi-sector partners. 

The Center’s outcomes may include: 

• Expand community capacity and 

knowledge to develop evidence-based 

program solutions, best practices and 

policies that address health disparities 

in AI/AN and NHPI populations. 

• Increase utilizations of effective 

strategies and tools to improve and 

reduce AI/AN and NHPI health 

disparities. 

• Contribute to improved AI/AN and 

NHPI health, elimination of health 

disparities, and achievement of health 

equity. 

II. Request for Information 

Through this RFI, OMH is seeking 

information from the following entities: 

Federally-recognized Indian Tribes/ 

American Indian and Alaska Native (AI/ 

AN) Tribes, Tribal organizations, Tribalserving organizations, Tribal Colleges 

and Universities, and AI/AN-serving 

institutions of higher education. 

A separate RFI exists to solicit 

feedback from Native Hawaiian and 

Pacific Islander (NHPI) communities. 

III. Questions 

• How might the proposed Center 

objectives and outcomes listed above 

meet the needs of AI/AN populations? 

• What is the recommended 

composition and governance 

infrastructure for the Center? 

• Are there specific focus areas and 

activities this center should address? 

Dated: February 9, 2021. 

Paul Rodriguez, 

Senior Advisor for Operations, Office of 

Minority Health. 

[FR Doc. 2021–02953 Filed 2–11–21; 8:45 am] 

BILLING CODE 4150–29–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

Federal Register / Vol. 86, No. 28 / Friday, February 12, 2021 / Notices 9355 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Clinical Neurophysiology, Devices, 

Neuroprosthetics, and Biosensors. 

Date: March 11–12, 2021. 

Time: 8:30 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Cristina Backman, Ph.D., 

Scientific Review Officer, ETTN IRG, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5211, 

MSC 7846, Bethesda, MD 20892, (301) 480– 

9069, cbackman@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Aging and Development, Auditory, 

Vision and Low Vision Technologies. 

Date: March 11–12, 2021. 

Time: 8:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Barbara Susanne Mallon, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institute of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 435–1042, mallonb@

mail.nih.gov. 

Name of Committee: Healthcare Delivery 

and Methodologies Integrated Review Group; 

Population and Public Health Approaches to 

HIV/AIDS Study Section. 

Date: March 11–12, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Jose H. Guerrier, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5222, 

MSC 7852, Bethesda, MD 20892, (301) 435– 

1137, guerriej@csr.nih.gov. 

Name of Committee: Healthcare Delivery 

and Methodologies Integrated Review Group; 

Interdisciplinary Clinical Care in Specialty 

Care Settings Study Section. 

Date: March 11–12, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Abu Saleh Mohammad 

Abdullah, Ph.D., Scientific Review Officer, 

Center for Scientific Review, 6701 Rockledge 

Drive, Bethesda, MD 20892, (301) 827–4043, 

abuabdullah.abdullah@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; ImmunoOncology Research. 

Date: March 11–12, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Mehrdad Mohseni, MD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5211, 

MSC 7854, Bethesda, MD 20892, (301) 435– 

0484, mohsenim@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Computational, Modeling and 

Biodata Management. 

Date: March 11, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Allen Richon, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6184, 

MSC 7892, Bethesda, MD 20892, (301) 379– 

9351, allen.richon@nih.hhs.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Infectious 

Diseases Clinical Research and Field Studies. 

Date: March 11–12, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Tera Bounds, Ph.D., DVM, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3198, 

MSC 7808, Bethesda, MD 20892, (301) 613– 

2822, boundst@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Biomedical Sensing, Measurement 

and Instrumentation. 

Date: March 11–12, 2021. 

Time: 9:00 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Yordan V. Kostov, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20817, (301) 867–5309, kostovyv@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Topics in 

Bacterial Pathogenesis. 

Date: March 11, 2021. 

Time: 9:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Richard G. Kostriken, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3192, 

MSC 7808, Bethesda, MD 20892, (240) 519– 

7808, kostrikr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Brain Disorders and Related 

Neurosciences. 

Date: March 11–12, 2021. 

Time: 9:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Vilen A. Movsesyan, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4040M, 

MSC 7806, Bethesda, MD 20892, (301) 402– 

7278, movsesyanv@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Digestive 

and Nutrient Physiology and Diseases. 

Date: March 11–12, 2021. 

Time: 9:30 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Aster Juan, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Bethesda, MD 20817, (301) 435–5000, 

juana2@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RFA–OD– 

20–005: Transformative Research Award for 

the INCLUDE Project (R01). 

Date: March 11, 2021. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Wenchi Liang, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3150, 

MSC 7770, Bethesda, MD 20892, (301) 435– 

0681, liangw3@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Interdisciplinary Clinical Care in Specialty 

Care Settings. 

Date: March 12, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Chittari V. Shivakumar, 

Ph.D., Scientific Review Officer, National 

Institutes of Health, Center for Scientific 

Review, 6701 Rockledge Drive, Bethesda, MD 

9356 Federal Register / Vol. 86, No. 28 / Friday, February 12, 2021 / Notices 

20892, (301) 408–9098, chittari.shivakumar@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

High Throughput Screening. 

Date: March 12, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: David Filpula, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6181, 

MSC 7892, Bethesda, MD 20892, (301) 435– 

2902, filpuladr@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 8, 2021. 

Tyeshia M. Roberson, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–02915 Filed 2–11–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Allergy and Asthma 

Statistical & Clinical Coordinating Center 

(AA–SCCC). 

Date: March 10, 2021. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G50, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Louis A. Rosenthal, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health 5601 

Fishers Lane, Room 3G50 Rockville, MD 

20852, (240) 669–5070, rosenthalla@

niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: February 8, 2021. 

Tyeshia M. Roberson, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–02916 Filed 2–11–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel; Review of Innovative Programs to 

Enhance Research Training (IPERT) 

Applications. 

Date: March 19, 2021. 

Time: 9:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892 (Video Meeting). 

Contact Person: Rebecca H. Johnson, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review, National Institute of General Medical 

Sciences, National Institutes of Health, 

Natcher Building, Room 3AN18C, 45 Center 

Drive, Bethesda, MD 20892, 301–594–2771, 

johnsonrh@nigms.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives; 93.859, 

Biomedical Research and Research Training, 

National Institutes of Health, HHS) 

Dated: February 8, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–02844 Filed 2–11–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; AD Model. 

Date: March 9, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Telephone Conference 

Call). 

Contact Person: Nijaguna Prasad, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Institute on Aging, National 

Institutes of Health, 7201 Wisconsin Avenue, 

Gateway Building, Suite 2W200, Bethesda, 

MD 20892, 301–496–9667, nijaguna.prasad@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: February 8, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–02843 Filed 2–11–21; 8:45 am] 

BILLING CODE 4140–01–P